Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interleukin-17”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Study completedNCT01169844
What this trial is testing

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 28
Post-approval studies (Phase 4)Study completedNCT02466646
What this trial is testing

Evaluation of Efficacy of Full-mouth Disinfection in Generalized Aggressive Periodontitis Patients

Who this might be right for
Aggressive Periodontitis
Marmara University 42
Large-scale testing (Phase 3)Active Not RecruitingNCT06945107
What this trial is testing

Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy

Who this might be right for
Plaque Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 308
Testing effectiveness (Phase 2)Ended earlyNCT03511365
What this trial is testing

Effects of Probiotic on Inflammation and Microbiota in Patients With NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseProbiotics MeSH Descriptor Data 2018Interleukin-17 MeSH Descriptor Data 2018
Northwell Health 6
Testing effectiveness (Phase 2)Study completedNCT02763111
What this trial is testing

Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Biocad 88
Post-approval studies (Phase 4)Not Yet RecruitingNCT06833112
What this trial is testing

Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
The Affiliated Hospital Of Guizhou Medical University 10
Not applicableStudy completedNCT03449186
What this trial is testing

Th17 Inducing Cytokines Pregnancy and After Postpartum

Who this might be right for
Pregnancy
Aydin Adnan Menderes University 114
Not applicableUnknownNCT01117077
What this trial is testing

The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis

Who this might be right for
Liver TransplantationAspergillusInterleukin-17+2 more
Shanghai Jiao Tong University School of Medicine 50
Not applicableActive Not RecruitingNCT06897722
What this trial is testing

Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls

Who this might be right for
Psoriasis (PsO)Periodontal Disease
Zhala Vatankha Sain 100
Early research (Phase 1)Study completedNCT02380287
What this trial is testing

First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Healthy Subjects

Who this might be right for
Healthy
Biocad 22
Not applicableStudy completedNCT06439095
What this trial is testing

Interleukin-2 (IL-2), Interleukin-5 (IL-5) and Interleukin-17 (IL-17) Levels of Patients With Stainless Steel Crowns

Who this might be right for
SalivaDental CrownNickel Sensitivity
Yuzuncu Yil University 12
Large-scale testing (Phase 3)Ended earlyNCT04237116
What this trial is testing

Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Plaque PsoriasisNon-alcoholic Fatty Liver Disease
Novartis Pharmaceuticals 10
Not applicableNot Yet RecruitingNCT07396194
What this trial is testing

Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Sohag University 84
Not applicableUnknownNCT06349135
What this trial is testing

Assessment of Serum Concentration of Interleukin-17 and Osteoprotegerin in Response to Surgical Trauma Induced by Management of Mandibular Fractures Via Intraoral Versus Extraoral Approaches: Prospective Cohort Study

Who this might be right for
Mandibular Fractures
Aya Ayman Ahmed 2
Not applicableStudy completedNCT05647187
What this trial is testing

Effect Narrow-Band UVB Radiations

Who this might be right for
Psoriasis VulgarisUVB Phototherapy Burn
South Valley University 80
Not applicableStudy completedNCT04299477
What this trial is testing

THE EFFETCS OF NON-SURGICAL PERIODONTAL TREATMENT ON SALIVARY BIOMARKERS OF PATIENTS WITH OSTEOPOROSIS AND PERIODONTITIS

Who this might be right for
OsteoporosisPeriodontitis
Gazi University 75
Early research (Phase 1)Study completedNCT02144272
What this trial is testing

Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

Who this might be right for
Inflammatory Arthritis
Eli Lilly and Company 41
Large-scale testing (Phase 3)Active Not RecruitingNCT04179175
What this trial is testing

Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Novartis Pharmaceuticals 703
Testing effectiveness (Phase 2)Study completedNCT01426789
What this trial is testing

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 100
Testing effectiveness (Phase 2)Study completedNCT01433250
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 39
Load More Results